PhilipCCaronMD
Oncology • West Harrison, NYAssistant Professor, Medicine, Weill Cornell Medical College
Overview of Dr. Caron
Dr. Philip Caron is an oncologist in West Harrison, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Phelps Memorial Hospital Center. He received his medical degree from New York Medical College and has been in practice 31 years. He is one of 497 doctors at Memorial Sloan Kettering Cancer Center and one of 19 doctors at Phelps Memorial Hospital Center who specialize in Oncology. He has more than 40 publications and over 500 citings.
Office
500 Westchester Avenue
West Harrison, NY 10604Fax+1 646-227-7283
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1989 - 1992
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1986 - 1989
New York Medical CollegeClass of 1986
Columbia UniversityPhD, Pathobiology, 1978 - 1984
Certifications & Licensure
FL State Medical License 2022 - Present
NY State Medical License 1987 - 2026
CT State Medical License 2023 - 2025
NJ State Medical License 2019 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Westchester Magazine: Top Doctors Castle Connolly
- Top Doctors: New York Metro Area Castle Connolly, 2003-2014
Publications & Presentations
PubMed
- 1 citationsZanubrutinib, Obinutuzumab, and Venetoclax for First-Line Treatment of Mantle Cell Lymphoma with a TP53 Mutation.Anita Kumar, Jacob D Soumerai, Jeremy S Abramson, Jeffrey A Barnes, Philip C Caron
Blood. 2024-10-22 - Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes.Jennifer K Lue, Efrat Luttwak, Alfredo Rivas-Delgado, Helen Irawan, Alexander Boardman
Blood Cancer Journal. 2024-10-14 - Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience.Giulio Cassanello, Esther Drill, Alfredo Rivas-Delgado, Michelle Okwali, Irem Isgor
Haematologica. 2024-09-05
Abstracts/Posters
- Central Nervous System Prophylaxis with High-Dose Intravenous Methotrexate or Intrathecal Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma and High-Risk of ...Philip Caron, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Retrospective Analysis of Gemcitabine and Oxaliplatin (GemOx)-Based Treatment in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin LymphomaPhilip Caron, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin LymphomaPhilip Caron, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Grant Support
- Targeted Sequential Therapy For CMLNational Cancer Institute1997–1998
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
